<html><head></head><body><p>Back to FDA Approvals 2004</p><h1>Human Secretin</h1><p>Generic Name: Secretin Synthetic Human<br/>
Date of Approval: April 9, 2004<br/>
Company: ChiRhoClin, Inc.<br/>
Treatment for: Secretin Stimulation Testing</p><ul class="ddc-anchor-links"><li>FDA approval</li></ul><h2 class="ddc-anchor-offset" id="fda-approval">FDA approves Human Secretin</h2><p>The FDA has approved three indications. The indications of Human Secretin are the following:</p><p>The FDA stated that they have completed the review of the NDA applications, as amended. The FDA has concluded that adequate information has been presented to demonstrate that the drug product is safe and effective for use as recommended in the agreed upon indications.</p><h2>More about Human Secretin (secretin)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: in vivo diagnostic biologicals</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Diagnosis and Investigation</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>